Life Science & Medical Technology
Tohoku University and precision equipment maker Shimadzu Corp. have jointly developed a system that checks exhaled breath to detect novel coronavirus infections.
Takeda Pharmaceutical Co. Ltd. is reportedly preparing to offer “stem cell therapy” in Japan as early as fiscal 2021.
Japan is advancing research to apply induced pluripotent stem cell (iPSC) to treat heart diseases. After the world’s first-of-its-kind iPSC-based heart cell transplant in January, a second clinical trial has been approved this summer and the third is in the pipeline. Currently, cardiac insufficiency can only be cured by transplants but the waiting list for a donor is long. There are hopes that the new treatment will provide new alternatives in the future.